ABEO: FDA Accepts BLA Re-Submission for Pz-cel PDUFA Date of April 29
On November 14, 2024, Abeona Therapeutics, Inc. (ABEO) announced financial results for the third quarter of 2024 and provided a business...
ABEO: Type A Meeting with FDA Concluded BLA Submission on Track for 2H24
On August 12, 2024, Abeona Therapeutics, Inc. (ABEO) announced financial results for the second quarter of 2024 and provided a business...
ABEO: BLA Resubmission in 2H24
On May 15, 2024, Abeona Therapeutics, Inc. (ABEO) announced financial results for the first quarter of 2024 and provided a business update. The...
No more insights